Strand Life Sciences, the premier in silico technologies innovation company announced today that it has entered into collaboration with Pharmidex, a world leader in assessing the ability of compounds to cross the blood-brain barrier (BBB).
Strand Life Sciences, the premier in silico technologies innovation company announced today that it has entered into collaboration with Pharmidex, a world leader in assessing the ability of compounds to cross the blood-brain barrier (BBB).